A detailed history of Met Life Investment Management, LLC transactions in Siga Technologies Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,976 shares of SIGA stock, worth $163,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,976
Previous 27,976 -0.0%
Holding current value
$163,659
Previous $212,000 11.32%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.32 - $10.46 $16,476 - $27,269
2,607 Added 10.28%
27,976 $212,000
Q1 2024

May 14, 2024

BUY
$4.51 - $8.92 $114,414 - $226,291
25,369 New
25,369 $217,000
Q2 2023

Apr 29, 2024

BUY
$5.0 - $6.31 $142,805 - $180,219
28,561 New
28,561 $144,000
Q1 2023

May 09, 2024

BUY
$5.23 - $8.42 $149,374 - $240,483
28,561 New
28,561 $164 Million
Q1 2022

May 10, 2024

BUY
$5.96 - $7.61 $170,223 - $217,349
28,561 New
28,561 $202,000
Q1 2022

Mar 22, 2023

BUY
$5.96 - $7.61 $60,923 - $77,789
10,222 Added 55.74%
28,561 $202,000
Q1 2022

May 12, 2022

BUY
$5.96 - $7.61 $60,923 - $77,789
10,222 Added 55.74%
28,561 $202,000
Q4 2021

Jun 21, 2023

SELL
$6.96 - $9.26 $71,145 - $94,655
-10,222 Reduced 35.79%
18,339 $137,000
Q3 2021

May 17, 2024

SELL
$5.71 - $7.39 $28,943 - $37,459
-5,069 Reduced 21.65%
18,339 $135,000
Q3 2021

Jun 21, 2023

SELL
$5.71 - $7.39 $58,367 - $75,540
-10,222 Reduced 35.79%
18,339 $135,000
Q3 2021

Mar 22, 2023

SELL
$5.71 - $7.39 $28,943 - $37,459
-5,069 Reduced 21.65%
18,339 $135,000
Q3 2021

Nov 15, 2021

BUY
$5.71 - $7.39 $104,715 - $135,525
18,339 New
18,339 $136,000
Q2 2021

Aug 16, 2021

SELL
$6.1 - $7.58 $142,788 - $177,432
-23,408 Closed
0 $0
Q1 2021

May 17, 2024

SELL
$6.3 - $7.71 $12,354 - $15,119
-1,961 Reduced 7.73%
23,408 $152,000
Q1 2021

Jun 26, 2023

SELL
$6.3 - $7.71 $32,463 - $39,729
-5,153 Reduced 18.04%
23,408 $152 Million
Q1 2021

Mar 22, 2023

BUY
$6.3 - $7.71 $95,148 - $116,444
15,103 Added 181.85%
23,408 $152,000
Q1 2021

May 14, 2021

BUY
$6.3 - $7.71 $95,148 - $116,444
15,103 Added 181.85%
23,408 $152,000
Q4 2020

May 24, 2024

SELL
$6.39 - $7.76 $93,587 - $113,652
-14,646 Reduced 63.81%
8,305 $60,000
Q4 2020

Jun 22, 2023

SELL
$6.39 - $7.76 $129,435 - $157,186
-20,256 Reduced 70.92%
8,305 $60,000
Q4 2020

Mar 22, 2023

SELL
$6.39 - $7.76 $93,587 - $113,652
-14,646 Reduced 63.81%
8,305 $60,000
Q4 2020

Feb 16, 2021

SELL
$6.39 - $7.76 $93,587 - $113,652
-14,646 Reduced 63.81%
8,305 $60,000
Q3 2020

Jun 26, 2023

SELL
$5.62 - $7.68 $31,528 - $43,084
-5,610 Reduced 19.64%
22,951 $157,000
Q2 2020

May 24, 2024

SELL
$4.55 - $6.19 $11,001 - $14,967
-2,418 Reduced 9.53%
22,951 $136 Million
Q2 2020

Jun 26, 2023

SELL
$4.55 - $6.19 $25,525 - $34,725
-5,610 Reduced 19.64%
22,951 $135,000
Q1 2020

Jul 12, 2023

SELL
$3.99 - $5.46 $22,383 - $30,630
-5,610 Reduced 19.64%
22,951 $109,000
Q4 2019

Jul 12, 2023

SELL
$4.34 - $5.86 $24,347 - $32,874
-5,610 Reduced 19.64%
22,951 $109,000
Q3 2019

Jul 12, 2023

SELL
$4.93 - $5.8 $27,657 - $32,538
-5,610 Reduced 19.64%
22,951 $117,000
Q2 2019

Jul 12, 2023

SELL
$5.22 - $6.1 $29,284 - $34,221
-5,610 Reduced 19.64%
22,951 $130,000
Q1 2019

Jul 13, 2023

SELL
$5.66 - $7.89 $31,752 - $44,262
-5,610 Reduced 19.64%
22,951 $137,000
Q4 2018

Jul 13, 2023

SELL
$4.77 - $7.9 $26,759 - $44,319
-5,610 Reduced 19.64%
22,951 $181,000
Q4 2018

Mar 22, 2023

SELL
$4.77 - $7.9 $96,268 - $159,437
-20,182 Reduced 46.79%
22,951 $181,000
Q4 2018

Feb 14, 2019

SELL
$4.77 - $7.9 $96,268 - $159,437
-20,182 Reduced 46.79%
22,951 $181,000
Q3 2018

Jul 13, 2023

SELL
$6.03 - $8.34 $33,828 - $46,787
-5,610 Reduced 19.64%
22,951 $158,000
Q3 2018

Mar 22, 2023

BUY
$6.03 - $8.34 $87,869 - $121,530
14,572 Added 51.02%
43,133 $297,000
Q3 2018

Nov 14, 2018

BUY
$6.03 - $8.34 $260,091 - $359,729
43,133 New
43,133 $297,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $427M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.